Farias, A., Soto, A., Puttur, F., Goldin, C. J., Sosa, S., Gil, C., . . . Berguer, P. M. (2021). A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment. Nature Portfolio.
Style de citation Chicago (17e éd.)Farias, A., A. Soto, F. Puttur, C. J. Goldin, S. Sosa, C. Gil, F. A. Goldbaum, et P. M. Berguer. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Farias, A., et al. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. Nature Portfolio, 2021.